The Regenerative Medicine Institute

Even the most successful people might have untapped brain potential! 🧠 We talked with the founder of BrainTap, Inc, Dr. Patrick Porter, about boosting brain energy levels and how you can elevate yours. Curious to learn more? Dive into our full podcast! 🎧

“Even if I do retire, am I just going to be in pain for the rest of my life?” – Liam Harrison That was Liam’s reality before he found RMI. Chronic knee pain and swelling had him considering retirement, not just from fighting but from the life he loved. After one transformative treatment at RMI, everything changed. With the pain gone and swelling reduced, he was back in the gym in just a month. Now, Liam is moving better, fighting stronger, and living pain-free. Watch how RMI helped Liam reclaim his life. #MuayThai #FighterRecovery #SportsMedicine #StemCellTreatment #KneePain #InjuryRecovery #PainRelief #AthleteLife #MobilityMatters #HealthyLiving #RegenerativeMedicine #SportsInjury #ChronicPain #ActiveLifestyle #JointHealth #painrelief #athleterecovery #stemcelltherapy #healthtransformation #LiamHarrison #athleteperformance

We sat down with former NBA star Steve Francis, who played for the Houston Rockets, Orlando Magic, and New York Knicks, to discuss the importance of maintaining physical health and the challenges that come with aging, even after a successful sports career. Steve shares his insights on the physical and mental demands of professional basketball, the lessons learned about body care, and how he’s using advanced treatments at RMI to keep pushing his limits.

Mesenchymal Stem Cells in Neurological Disorders: A New Frontier in Regenerative Medicine?  Neurological diseases like stroke, Alzheimer’s, and spinal cord injuries have long been considered difficult to treat due to the limited regenerative capacity of the central nervous system. However, recent advancements in the use of mesenchymal stem cells are opening new doors for therapeutic options! #StemCells #Neurology #RegenerativeMedicine #Healthcare #Research

🏥 Advancing MSC-Based Therapies at RMI: Standardization and Quality Assurance While MSC-based therapies show great promise for treating knee osteoarthritis, their integration into routine clinical practice faces significant challenges, particularly in terms of treatment standardization. At RMI, our focus is on overcoming these challenges by standardizing these innovative treatments and adhering to the most demanding quality standards. Our Commitment: - Standardization of Treatments: We are dedicated to developing consistent protocols that ensure the efficacy and safety of MSC-based therapies. This includes rigorous control of cell source, preparation methods, and delivery techniques. - Quality Assurance: At RMI, we follow stringent quality control measures to guarantee that our therapies meet the highest standards. This ensures that our patients and the medical community receive consistent and reliable results. - Overcoming Clinical Hurdles: By addressing variability in cell preparation and establishing clear clinical protocols, we aim to pave the way for these therapies to become a standard part of osteoarthritis management. Our efforts are not just about improving individual outcomes but also about setting a benchmark in the field of regenerative medicine. #HealthcareChallenges #ClinicalTrials #Orthopedics #QualityInHealthcare

Subchondroplasty is a great treatment with great results for Hip and Knee osteoarthritis. We use high quality cellular treatments to ensure our patients get the best possible results. https://lnkd.in/d5P527kr

We are Turning the Tide Against Multiple Sclerosis with Stem Cell Breakthroughs 🧬   Exciting news! Our study on umbilical cord stem cells to treat relapsing-remitting multiple sclerosis (MS) has been accepted by the Principles and Practice of Clinical Research Journal.   This is a big win for MS research!   This journal is a prestigious platform dedicated to advancing clinical research methodologies and innovative medical treatments. Being featured in such a journal highlights our commitment at RMI to pioneering therapies that push the boundaries.   This study marks a significant step forward in the battle against MS, showcasing the limitless potential of stem cells in regenerative medicine. Yet, we acknowledge that much more needs to be done in this ongoing fight—we need more resources and collaborative efforts to bring these groundbreaking therapies to more patients.   At RMI, we are driven by the mission to lead the way in non-surgical regenerative treatments for diseases like MS.   Together, we are redefining what’s possible in healthcare.     RMI Study: “Protocol for a Pilot Phase IIa Randomized, Placebo-Controlled, Double-Blind, Crossover Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Relapsing-Remitting Multiple Sclerosis: The MSCell Study" #StemCellResearch #RegenerativeMedicine #MSAwareness #Longevity

Mesenchymal Stem Cells in Sports Medicine: A Promising Approach for Soccer Injuries Injuries in soccer can be career-altering, but MSCs are transforming recovery. By promoting faster tissue repair and reducing inflammation, MSC therapies are helping athletes return to the field stronger and sooner. From ligament tears to cartilage damage, MSCs are revolutionizing sports medicine with their regenerative potential. Could MSCs be the future of injury recovery in soccer? Let’s dive into the exciting possibilities!

Using plasmapheresis combined with anti-ACE2 and anti-FcγRII monoclonal antibodies as a novel treatment for severe COVID-19 cases. Here’s what the research suggests: 🔬 Therapeutic Strategy: - Plasmapheresis: Aimed at removing pro-inflammatory cytokines, antibodies, and immune complexes, potentially halting antibody-dependent enhancement (ADE) and reducing cytokine storms. - Monoclonal Antibodies: Targeting ACE2 and FcγRII receptors to prevent viral entry into host cells and modulate immune response. 🧬 Key Findings: - This dual approach could effectively stop the progression of acute respiratory distress syndrome (ARDS) and multi-organ failure, especially in patients unresponsive to conventional therapies. - By reducing the severity of the initial infection and controlling excessive immune responses, these interventions might lower the risk of developing long COVID symptoms, improving long-term recovery outcomes. 💡 Future Implications: - Clinical trials are necessary to validate the safety and efficacy of this treatment. Success could pave the way for new protocols in managing severe viral infections and preventing long-term complications like long COVID. Read the full study: https://lnkd.in/gRR-385q #COVID19 #MonoclonalAntibodies #Plasmapheresis #MedicalResearch #TherapeuticInnovation #Healthcare #LongCOVID #ViralInfections